Novel transcript, antisense to DAPL1

The target designated "novel transcript, antisense to DAPL1" (ENSG00000286621) is an annotated non-coding RNA sequence, transcribed antisense to the DAPL1 gene locus. It does not encode a known protein product, does not have known aliases or abbreviations, and is not categorized as a therapeutic target or receptor. No molecular function, biological role, involvement in disease, drug interactions, or clinical relevance has been established for this transcript, and as such, it is not considered a meaningful target for therapeutic intervention. This differs from DAPL1 itself, which is a protein-coding gene with research evidence indicating potential roles in epithelial differentiation, apoptosis, and immune cell regulation[1][3]. If your request pertains to the DAPL1 gene/protein rather than this antisense transcript, please specify, as DAPL1 is a protein with known cellular roles and disease associations (e.g., in cataracts or immune modulation)[1][3].

Other names

ENSG00000286621novel antisense transcript at DAPL1 locus